CVI Holdings’s vTv Therapeutics VTVT Stock Holding History

CVI Holdings’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30,729	Closed	-$2.1M	–	75
2019 Q1	$2.1M	Buy	+30,729	New	+$2.98M	1.99%	11

Other funds holding VTVT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CVI Holdings's VTVT Position: Q2 2019 in Review

CVI Holdings sold out of vTv Therapeutics (VTVT) in Q2 2019, closing a stake of 30,729 shares — an estimated $2.1M sold.

CVI Holdings first reported a position in VTVT in Q1 2019 and held it in 1 quarter. The position peaked at $2.1M in Q1 2019. 20 funds tracked by Wall St. Rank hold VTVT as of Q2 2019.

CVI Holdings reported no remaining vTv Therapeutics position as of Q2 2019 after selling out during the quarter.
CVI Holdings sold 30,729 vTv Therapeutics shares in Q2 2019, an estimated $2.1M.
CVI Holdings first reported a position in vTv Therapeutics in Q1 2019 and held it in 1 quarter.
CVI Holdings's vTv Therapeutics position peaked at $2.1M in Q1 2019.
20 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2019.

Based on CVI Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.